SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
Mayo Clinic
Nkarta, Inc.
Masonic Cancer Center, University of Minnesota
Morphotek
Rutgers, The State University of New Jersey
Cellerant Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Northwestern University